Qure Reviews, Read Properly: What Qure Publishes, What Third Parties Show, and Where the Numbers Disagree
Competitor review, written by a competitor
On 23 August 2026 Qure was the most widely recommended at-home micro-infusion system we could find. Google’s AI Overview called it the best overall, the biggest affiliate listicle in the category ranked it first, and its shopping panel carried thousands of ratings. Before you buy one, here is what Qure’s own page states, where its published figures differ, what three separate rating sources show, and how the system compares with the EvenSkyn MicroInfuser on specifications.
Weighing Qure against Seranova? See Seranova vs Qure side by side, spec by spec, with Glov and six other kits.
The short version
Qure makes a competent, well-marketed 0.5 mm micro-infusion system with two targeted serums, disposable heads and a clearly stated treatment cadence. On the hardware there is very little separating it from the EvenSkyn MicroInfuser or from Seranova. Stated needle length is the same, needle material is the same, single-use heads are the same, and the recommended frequency is the same across all three.
Three things are worth knowing before you buy. Qure’s micro-infusion page offers a 90-day money-back guarantee that asks for before-and-after photos after every treatment, and on 21 October 2026 its 6-month bundle page showed a 30-day window. Its headline efficacy figure, 93% noticing results the next day, comes from a user study of 30 participants. And its three public rating figures, first-party, Trustpilot and Google, are 4.8, 4.5 and 4.4 across very different review counts.
None of that makes Qure a bad product. It makes it a heavily marketed one, which is a different thing, and it is worth being able to tell those apart when the entire first page of Google is recommending it to you.
What Qure is
Qure Skincare sells an at-home micro-infusion system: a serum vial and a disposable needle head that screws onto it. You stamp rather than roll, and the serum is applied as you stamp. It is the same treatment category as the EvenSkyn MicroInfuser, Seranova, Glov and AMIRO.
Qure’s distinguishing choice is that it splits its formula in two. Instead of one serum meant to do everything, you pick a Brightening serum for dark spots or a Rejuvenating serum for fine lines, or a mixed supply of both. That is a genuinely reasonable design decision and it is the thing we would point to if asked what Qure does better than the rest of the category.
What Qure states about its own product, read on 23 August 2026 unless a later date is shown
| Attribute | What Qure’s page states |
|---|---|
| Needle length | 0.5 mm |
| Needle material | 24K gold-plated |
| Needle count | Not stated |
| Needle head | Disposable. “New needle heads provide sharp, straight needles for every treatment” |
| Sterilisation | “EO-sterilized (ethylene oxide)” |
| Serums | Brightening and Rejuvenating, also offered as a Mixed supply (read 10 November 2026) |
| Brightening ingredients include | Tranexamic acid, niacinamide, panthenol, Tripeptide-1, sh-Oligopeptide-1 (read 10 November 2026). Concentrations not stated |
| Rejuvenating ingredients include | Beta-glucan, Copper Tripeptide-1, sodium hyaluronate, niacinamide, panthenol (read 10 November 2026). Concentrations not stated |
| Frequency | “Every 2 weeks for best results” |
| Price seen | On 23 August 2026: $119.00 for a Micro-Infusion 1 Month Bundle (Brightening) on qureskincare.com, and $169.00 against $357 on Google’s shopping panel. On 10 November 2026: 1 Month Supply at $99 on subscription, shown against $119 |
| Treatments per bundle | 2 in the 1 Month Supply, 6 in the 3 Month Supply, 12 in the 6 Month Supply (read 10 November 2026) |
| Guarantee | “90-Day Money-Back Guarantee” and “30-Day Money-Back Guarantee” both appeared. On 21 October 2026 the micro-infusion page showed only the 90-day guarantee, with before-and-after photos required after each two-week treatment, and the 6-month bundle page showed a 30-Day Money-Back Guarantee |
| Efficacy claim | “93% noticed results the next day after their first Micro-Infusion treatment” (read 10 November 2026) |
| Study cited | “Based on a user study of 30 participants aged 25-65” (read 10 November 2026) |
| Professional claim | “50+ Board Certified Dermatologists recommend Qure to their patients” |
| First-party rating | “4.8/5 Rated by 10k+ Customers”, with 4,588 reviews shown on one bundle |
Three things to check in Qure’s published numbers
These are not accusations. They are what a careful reader finds on Qure’s own pages, and each one is checkable by opening the page yourself.
1. Two money-back windows on one page, in August
On 23 August 2026 a 90-Day Money-Back Guarantee and a 30-Day Money-Back Guarantee both appeared, sixty days apart. That is a common pattern when a promotional banner and a standing policy live on the same template. When we read the page again on 21 October 2026, only the 90-day guarantee appeared, and its FAQ sets the conditions: 90 days of consistent use, and before-and-after photos taken after each two-week treatment. The same day, the 6-month bundle page showed a 30-Day Money-Back Guarantee, so the two numbers now sit on different pages. Get the terms that apply to your order in writing before you buy.
2. What the 93% figure rests on
Qure states that 93% noticed results the next day after their first treatment. The footnote under that figure reads “Based on a user study of 30 participants aged 25-65” (read 10 November 2026). That is a small sample, and the footnote does not say who conducted the study.
The deeper point is about what a next-day change can be. Any micro-infusion session can leave skin looking briefly plumper and better hydrated, and that is visible in a mirror the following morning. It is a real effect. It is also a temporary one, and it is not evidence of the longer-term change in the look of skin these products are usually bought for. We apply the same standard to ourselves: our own testing is company-sponsored, unpublished and not peer-reviewed, and we say so wherever we cite it.
3. Three rating sources, three different numbers
| Source | Rating | Count | Read on |
|---|---|---|---|
| Qure’s own site | 4.8 / 5 | “10k+ customers”, 4,588 reviews on one bundle | 23 Aug 2026 |
| Trustpilot profile for qureskincare.com, as displayed in Google’s results | 4.5 / 5 | about 1,588 reviews | 23 Aug 2026 |
| Google shopping panel | 4.4 / 5 | about 1,300 ratings | 23 Aug 2026 |
A first-party number sitting above third-party numbers is normal and not by itself suspicious. Brands collect reviews from every buyer; independent platforms collect from people motivated enough to go elsewhere and write one. What is worth taking from this is simply that no single figure here is the truth, and 4.8 from 10,000 is doing more marketing work than 4.4 from 1,300.
The claim we could not check
“50+ Board Certified Dermatologists recommend Qure to their patients.” We looked for names, institutions, credentials or any disclosure of whether those clinicians were compensated, and found none published. The claim may be entirely accurate. It is not currently verifiable, and an unverifiable endorsement is not a reason to choose a product over another one.
We hold ourselves to the same line. EvenSkyn works with a Chief Dermatology Advisor and we name that role and that relationship rather than implying a broader consensus we cannot evidence.
Qure's comparison article, fact-checked
On 31 August 2026 we read Qure's own comparison article, titled "Qure vs Seranova vs Glov: Full Comparison", attributed to "Our Editorial Team" with no publication date shown. It compares three kits and does not mention EvenSkyn. Because it has become one of the most visible comparison pages in the category, we checked its factual claims the way we check everything else on this page: against primary sources, with the same standard applied to ourselves. Qure also publishes a separate seven-kit comparison, read on 10 November 2026, that includes the EvenSkyn MicroInfuser.
The FDA sentence, checked against the FDA's page
The article states: "The FDA notes that devices with shorter, blunter needles used mainly to support serum absorption or the look of skin generally aren't classified as medical devices."
The FDA's microneedling devices page, read in full on 30 August 2026, states the conditions differently: "Generally, microneedling products that do not penetrate into the living skin layers (epidermis and dermis) and claim only to do the following would not be devices: Facilitate exfoliation of the skin (that is, disruption or removal of the stratum corneum); Improve the appearance of skin; Give skin a smoother look and feel; Give skin a luminous look." The same page states: "Microneedling devices are not approved for delivery of cosmetics, topical medications (for example, creams, ointments, gels), vitamin solutions, drugs, or blood products (for example, platelet-rich plasma (PRP)) into the skin."
Two differences matter. First, the FDA's non-device conditions are that a product does not penetrate living skin and claims only appearance-level effects. Supporting serum absorption is not among the listed claims, and the FDA separately states that microneedling devices are not approved to deliver cosmetics into the skin. Second, the FDA's sentence says nothing about shorter or blunter needles; that condition is the article's, not the FDA's. The full FDA wording is quoted and linked on our device-category reference, with every source used here.
The claims that check out
The article states Glov's needle length as 0.25 mm. That matches Glov's main product page as read on 31 August 2026, and it is fair to note that the ground moved under everyone here: Glov's own pages stated 0.5 mm in July 2026. The article's Qure specifications, 0.5 mm needles, 24K gold plating, EO sterilisation and an every-two-weeks cadence, match Qure's own product page read the same day. Its description of Seranova's serum matches Seranova's current ingredient marketing.
A wording worth reading twice
The article says the Qure system is "backed by an independent 31-subject clinical evaluation across all Fitzpatrick skin types". Qure's product page describes that evaluation as an "independent clinical evaluation of dermatologic safety-in-use". A safety-in-use evaluation examines tolerance, not results, so "backed by" is carrying more weight in that sentence than the evaluation it points to. Qure's separate efficacy figure and study description are examined earlier on this page.
What the article does not contain
No prices appear for any of the three kits, and the comparison covers three brands in a category of at least ten. For every brand's published facts in one dated table, see the micro-infusion disclosure ledger.
Qure and the EvenSkyn MicroInfuser, spec by spec
Read the ties first. On most of what actually happens to your skin, these two products are the same, and any comparison that hides that is selling you something.
| Specification | Qure | EvenSkyn MicroInfuser | Who wins |
|---|---|---|---|
| Needle length as stated | 0.5 mm | 0.5 mm nominal, fixed at the head | Tie |
| Needle material | 24K gold-plated | 24 karat gold-plated | Tie |
| Head reuse | Disposable, new head each treatment | Single use, new head each treatment | Tie |
| Sterilisation stated | Ethylene oxide | Individually gamma-sterilised | Tie, both disclose, which most of the category does not |
| Serum path | Capped serum vial, the needle head screws straight onto it (read 10 November 2026) | Sealed ampoule connecting directly to the head | Tie |
| Serum actives | Brightening: tranexamic acid, niacinamide, Tripeptide-1, sh-Oligopeptide-1. Rejuvenating: beta-glucan, Copper Tripeptide-1, sodium hyaluronate (read 10 November 2026) | Biosynthetic PDRN at 2,000 ppm, Copper Tripeptide-1, sh-Oligopeptide-1 | EvenSkyn, if PDRN is what you want |
| Targeted formulas | Two, dark spots or wrinkles, chosen at purchase | One combined formula | Qure |
| Concentrations published | No (read 10 November 2026) | Yes, PDRN stated at 2,000 ppm, which is 0.2% | EvenSkyn |
| Entry price | 1 Month Supply, 2 treatments: $99 on subscription, shown against $119 (read 10 November 2026) | $179.98 for the kit, 4 treatments | Qure |
| Treatments stated | 2, 6 or 12, depending on the supply (read 10 November 2026) | 4 sealed ampoules, sold as a 2 month supply | Tie |
| Cost per treatment | $49.50 on the 1 Month Supply ($99 for 2) and $16.58 on the 6 Month Supply ($199 for 12). Subscription prices read 10 November 2026, our arithmetic | $44.99 | Depends on the supply. Qure is cheaper per treatment on its 6 Month Supply |
| Frequency | Every 2 weeks | Every 2 weeks | Tie |
| Money-back window | 90 days on the micro-infusion page, with before-and-after photos required after each treatment; 30 days on the 6-month bundle page (both read 21 October 2026) | 60 days; each unused, sealed treatment refunded at 25% of the kit price | Tie, depending on which Qure kit you buy |
| Public review volume | Thousands, across three sources | Far fewer, and we do not publish a rating on the product page | Qure, clearly |
| Availability today | Shipping | Shipping | Tie |
That is nine ties, three lines where Qure is the better buy, two where we would argue ours is, and one, cost per treatment, that depends on the supply you buy. We are not going to pretend the review-volume line is a small one. If social proof is what you buy on, Qure has thousands of public reviews and we do not, and no amount of specification detail changes that.
The one difference that actually matters
Strip out everything both brands share and one substantive difference is left: what is in the ampoule.
Qure’s published formulas are built on tranexamic acid, beta-glucan, niacinamide, sodium hyaluronate and panthenol. Its ingredient lists also include Tripeptide-1 and sh-Oligopeptide-1 in the Brightening serum and Copper Tripeptide-1 in the Rejuvenating serum (read 10 November 2026). Those are good, widely used topical ingredients. Neither formula lists PDRN.
The EvenSkyn Syntha-Pep ampoule is built around biosynthetic PDRN at 2,000 ppm, with Copper Tripeptide-1 and sh-Oligopeptide-1. PDRN is a large molecule, and what it does for the look of skin when used with a micro-infusion kit has not been measured in a published study, ours included. We have written a page on exactly that question, including what nobody has measured, and we recommend reading it before you take our word for it.
So the honest framing is not that one device is better made. It is that a micro-infusion kit earns its price on what is in the ampoule, disclosed and checkable. That is the question to put to any brand in this category, including us.
Who should pick which
Pick Qure if:
- You want the lower up-front price of the two.
- Your concern is specifically dark spots and you want a formula built around tranexamic acid.
- Large public review volume is how you decide, and you want to read a thousand strangers before you buy.
- You want the option to switch formulas between wrinkle and pigment concerns over time.
Pick the EvenSkyn MicroInfuser if:
- You want PDRN, a copper peptide and a growth factor in one sealed, single-use ampoule.
- You want the actives and the concentration published rather than listed without numbers.
Pick neither if: you have active acne, an eczema or rosacea flare, have taken isotretinoin recently, are pregnant, or scar easily. That advice applies to every product named on this page including ours, and it is covered properly on our safety page.
Where we stand
We are not going to end a page about a competitor by telling you the competitor is bad. Qure makes a real product, states its needle length consistently, uses disposable heads, names its sterilisation method and publishes a cadence. Most of this category does less than that.
What we would ask you to do is separate the marketing from the specification. Qure is winning the recommendation layer right now, and a first page of Google that agrees with itself is not the same as evidence. Read both ingredient lists, including ours in declaration order, decide which formula you want on your skin, and buy on that.
Frequently asked questions
Is Qure Skincare a legitimate company?
Yes. Qure sells a real product from a real storefront, ships internationally, operates country domains for Germany and France, and carries a public Trustpilot profile with roughly 1,650 reviews (read 10 November 2026). Nothing on this page suggests otherwise. The questions worth asking about Qure are about its published claims, not its existence.
Does Qure micro-infusion actually work?
Qure cites a user study of 30 participants aged 25 to 65 for its results figures, and separately an independent safety-in-use evaluation of 31 subjects, which looked at tolerance rather than results (both read 10 November 2026). The footnote does not say who conducted the user study, and we could not find it published in a peer-reviewed journal. A small unpublished user study is limited evidence. Qure’s stated needle length is the same 0.5 mm as ours and as Seranova’s, so on the needles themselves there is little separating these products.
How much does Qure micro-infusion cost?
On 10 November 2026 Qure’s page listed, on subscription, a 1 Month Supply of 2 treatments at $99 (shown against $119), a 3 Month Supply of 6 treatments at $127 and a 6 Month Supply of 12 treatments at $199. By our arithmetic that is $49.50, $21.17 and $16.58 a treatment. When we first read the page on 23 August 2026 it listed a Micro-Infusion 1 Month Bundle at $119.00, and Google’s shopping panel showed a Qure micro-infusion listing at $169.00 against a $357 compare-at price, so the figure depends on which supply and which surface you land on. Prices change, so check Qure’s page before you buy.
What is Qure’s needle length?
0.5 mm, and Qure states it consistently. Their page describes 24K gold-plated needles at 0.5 mm. That matches the EvenSkyn MicroInfuser and Seranova’s headline figure. Needle length is not where these products differ.
Are the Qure needle heads reusable?
No. Qure describes disposable heads and states that new heads provide sharp, straight needles for every treatment. That is the correct design for this category and it matches ours.
How are Qure needle heads sterilised?
Qure states EO sterilisation, meaning ethylene oxide. The EvenSkyn MicroInfuser heads are individually gamma-sterilised. Both are recognised methods for single-use devices. Ethylene oxide is a chemical process and requires an aeration step afterwards to bring residual levels down; gamma irradiation is a physical process and leaves no chemical residue. Neither method is a problem in itself, and the notable thing is that both brands name their method at all, which most of this category does not.
What is in the Qure serums?
Qure sells two, read on 10 November 2026: a Brightening serum whose ingredient list includes tranexamic acid, niacinamide, panthenol, Tripeptide-1 and sh-Oligopeptide-1, and a Rejuvenating serum whose list includes beta-glucan, Copper Tripeptide-1, sodium hyaluronate, niacinamide and panthenol. Concentrations are not published. Those are sensible, widely used ingredients.
Does Qure contain PDRN?
No. Neither published Qure formula lists PDRN (read 10 November 2026). Both brands use peptides: Qure’s Brightening serum lists Tripeptide-1 and sh-Oligopeptide-1, and its Rejuvenating serum lists Copper Tripeptide-1. PDRN is the formulation difference between the two brands. The EvenSkyn Syntha-Pep ampoule is built around biosynthetic PDRN at 2,000 ppm with Copper Tripeptide-1 and sh-Oligopeptide-1, a figure taken from the formulation and safety summary we publish. Whether that matters to you depends on which ingredients you want in the ampoule.
How often should you use Qure?
Every two weeks, which is what Qure’s own page recommends. That is the same cadence we recommend for the MicroInfuser, and the same one Seranova publishes. Nobody in this category is arguing about frequency.
What is Qure’s return policy, 30 days or 90 days?
On 21 October 2026 the Qure micro-infusion page showed a 90-Day Money-Back Guarantee. Its FAQ describes a refund if you see no improvement after 90 days of consistent use, provided you submit before-and-after photos taken after each two-week treatment. The same day, the Qure 6-month bundle page showed a 30-Day Money-Back Guarantee, with no conditions stated. When we first read the micro-infusion page, on 23 August 2026, it showed a 90-day and a 30-day money-back guarantee at the same time. Get the terms that apply to your order in writing before you buy.
What does “50+ board certified dermatologists recommend Qure” actually mean?
We could not establish that. Qure states it on its page. No names, credentials, institutions or disclosure of whether those dermatologists were compensated appear alongside the claim, and we could not find a public list. It may be entirely accurate. It is not currently checkable, and a claim you cannot check should not be the reason you buy something.
Is the “93% noticed results the next day” claim reliable?
Treat it carefully. Qure states that 93% noticed results the next day after their first treatment, based on a user study of 30 participants aged 25 to 65 (read 10 November 2026). That is a small sample, and the footnote does not say who conducted the study. Beyond that, a next-day change after any micro-infusion session is most plausibly hydration and mild local swelling, which is real and visible and also temporary. It is not the same thing as a structural change, and no at-home device in this category should be sold as though it were.
What do Qure’s ratings actually say?
Three sources give three different numbers, and all three are worth knowing. Qure’s own page states 4.8 out of 5 from more than 10,000 customers, with 4,588 reviews shown on one bundle. Trustpilot’s public rating for qureskincare.com, as shown in Google’s search results on 23 August 2026, was 4.5 from about 1,588 reviews. Google’s own shopping panel showed 4.4 from about 1,300 ratings the same day. First-party review counts are usually higher than third-party ones because they collect from every buyer rather than from people motivated to go and write somewhere else. The pattern here is normal. The spread is worth seeing before you treat any single figure as the truth.
Qure or Seranova, which is better?
On the specifications both publish, they are close to identical: 0.5 mm, 24 karat gold-plated needles, disposable heads, every two weeks. The real differences are the serums and the buying experience. Qure splits its formula in two so you choose between dark spots and wrinkles; Seranova sells one combined formula. We have written a separate page on Seranova and we reach the same conclusion there: needle length is not the deciding factor in this category, and anyone telling you it is has not read all three brands’ pages.
Qure or the EvenSkyn MicroInfuser, what is the actual difference?
Two things. First, the serum: ours combines PDRN with a copper peptide and sh-Oligopeptide-1 in one formula. Qure’s formulas do not list PDRN, and split their actives between a Brightening and a Rejuvenating serum. Second, the price and what it buys: on 10 November 2026 Qure’s 1 Month Supply of two treatments was $99 on subscription, and ours is $179.98 for four sealed treatments, which is $44.99 each. Qure’s 6 Month Supply works out lower per treatment than ours. Everything else, needle length, needle material, single-use heads, a head that attaches straight to the serum container, cadence, is the same. If cost of entry is the deciding factor, Qure wins that line. If you want PDRN in the ampoule, we would argue ours does.
Is Qure FDA approved?
Qure’s product page makes no FDA approval or clearance claim (read 10 November 2026). The EvenSkyn MicroInfuser is not FDA-approved or FDA-cleared either. Whether a microneedling product is regulated as a medical device depends on its design and on the claims made for it, and the FDA explains the distinction on its microneedling devices page.
Related reading
- Best micro-infusion system: every at-home kit compared
- Seranova reviews, read properly
- Glov Beauty reviews, read properly
- Micro-infusion safety and contraindications
- Does topical PDRN get into skin?
- What is actually in Syntha-Pep
Sources, with the date each was read
- Qure Skincare, Micro-Infusion 6-Month Bundle for Dark Spots product page, qureskincare.com/products/micro-infusion-6-month-bundle-for-dark-spots, read 21 October 2026. Source for the 30-day money-back guarantee.
- Qure Skincare, Micro-Infusion product page, qureskincare.com/pages/microinfusion. Source for price, needle length and material, disposable heads, ethylene oxide sterilisation, both serum ingredient lists, the money-back terms (read 23 August and 21 October 2026), the every-two-weeks cadence, the 93% claim, the 30-participant study description, the dermatologist claim and the first-party rating. Read again on 10 November 2026 for the supply prices and treatment counts, the serum names and ingredient lists, the serum loading step, the study footnote and the safety-in-use evaluation.
- Qure Skincare, "Microinfusion System Alternatives 2026: At-Home Kits Compared", qureskincare.com/blogs/all/microinfusion-system-alternatives, read 10 November 2026.
- Trustpilot profile for qureskincare.com, trustpilot.com/review/qureskincare.com, review count read 10 November 2026.
- Trustpilot profile for qureskincare.com, rating and review count as displayed in Google search results on 23 August 2026.
- Qure Skincare, "Qure vs Seranova vs Glov: Full Comparison", qureskincare.com/blogs/all/qure-vs-seranova-vs-glov, read 31 August 2026. Source for every claim attributed to Qure's comparison article above.
- FDA, Microneedling Devices page, fda.gov/medical-devices/aesthetic-cosmetic-devices/microneedling-devices, read in full 30 August 2026. Source for the FDA quotations in the fact-check section.
- Google shopping panel for Qure micro-infusion, price, compare-at price, rating and rating count as displayed on 23 August 2026.
- Google United States search results for “best micro infusion system” and “qure vs seranova micro infusion”, including the AI Overview and its cited sources, captured 23 August 2026.
- EvenSkyn MicroInfuser product page and micro-infusion safety page, evenskyn.com, for every EvenSkyn figure quoted above.
Prices, ratings and published claims change. Every figure above is stamped with the date we read it. If you are reading this much later, open the sources and check.




